Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anfibatide in acquired thrombotic thrombocytopenic purpura
NCT04021173Phase 2Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Jul 2019
- Primary completion
- Jul 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of anfibatide in thrombotic thrombocytopenic purpura (TTP), sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
anfibatide
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on NCT04021173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04021173.